In the US, copyright enterprise?GH Analysis went community and at the moment enjoys a sector capitalisation of all around $850 million, although ATAI Lifestyle Sciences, backed by billionaire Peter Thiel and with 4 medications in scientific trials on the run,?has fallen from an analogous valuation t